IRIS
BERTINO, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.463
EU - Europa 3.421
AS - Asia 2.610
SA - Sud America 645
AF - Africa 398
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
Totale 13.555
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.166
SG - Singapore 1.429
IT - Italia 990
CN - Cina 873
IE - Irlanda 871
UA - Ucraina 781
BR - Brasile 605
CI - Costa d'Avorio 271
CA - Canada 269
RU - Federazione Russa 227
DE - Germania 117
SE - Svezia 107
GB - Regno Unito 79
SN - Senegal 78
IN - India 70
VN - Vietnam 51
FR - Francia 45
FI - Finlandia 35
NL - Olanda 32
BE - Belgio 26
KR - Corea 26
UZ - Uzbekistan 26
TR - Turchia 23
AT - Austria 21
CZ - Repubblica Ceca 20
CH - Svizzera 18
BD - Bangladesh 17
PL - Polonia 15
GR - Grecia 14
MA - Marocco 14
AR - Argentina 13
MX - Messico 13
IQ - Iraq 12
EU - Europa 10
IR - Iran 10
NG - Nigeria 10
HK - Hong Kong 9
ZA - Sudafrica 9
PK - Pakistan 8
QA - Qatar 7
SA - Arabia Saudita 7
CO - Colombia 6
LB - Libano 6
NP - Nepal 6
AU - Australia 5
BG - Bulgaria 5
IL - Israele 5
JP - Giappone 5
KE - Kenya 5
UY - Uruguay 5
ES - Italia 4
JM - Giamaica 4
KZ - Kazakistan 4
PA - Panama 4
PE - Perù 4
PY - Paraguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
HN - Honduras 3
HR - Croazia 3
JO - Giordania 3
LT - Lituania 3
RO - Romania 3
EC - Ecuador 2
ET - Etiopia 2
GA - Gabon 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
IM - Isola di Man 1
KG - Kirghizistan 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 13.555
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.128
Singapore 872
Dublin 867
Chandler 753
Jacksonville 691
Chicago 394
Boardman 350
Abidjan 271
Nanjing 248
Lawrence 242
Andover 240
Cambridge 240
Toronto 217
Catania 184
Houston 138
Ashburn 127
Des Moines 126
Wilmington 99
San Mateo 98
Civitanova Marche 97
Dakar 78
Shenyang 75
Nanchang 69
Saint Petersburg 66
Beijing 58
Hebei 54
Council Bluffs 53
Hefei 52
Milan 52
Changsha 50
Bremen 46
Ottawa 46
São Paulo 46
The Dalles 45
Los Angeles 44
Tianjin 43
Jiaxing 42
Mountain View 41
Columbus 38
Palermo 33
Dong Ket 29
Munich 27
Rome 27
Brussels 26
Seoul 26
Kochi 25
Moscow 24
Mascalucia 21
Turku 21
Belo Horizonte 19
New York 18
Norwalk 16
Rio de Janeiro 16
Brooklyn 15
Falls Church 15
Mumbai 15
Redmond 14
London 13
Seattle 13
Brasília 12
Brno 12
Foggia 12
Hanoi 12
Jinan 12
Leawood 12
Pune 12
Washington 12
Amsterdam 11
Kunming 11
Modica 11
Naples 11
Tashkent 11
Abuja 10
Den Haag 10
Liberty Lake 10
Florence 9
Helsinki 9
Hong Kong 9
Porto Alegre 9
Dhaka 8
Gravina di Catania 8
Hangzhou 8
Ningbo 8
San Francisco 8
Turin 8
Zhengzhou 8
Baghdad 7
Frankfurt Am Main 7
Istanbul 7
Phoenix 7
Siracusa 7
Uberlândia 7
Warsaw 7
Ardabil 6
Atlanta 6
Bari 6
Carlentini 6
Chennai 6
Contagem 6
Goiânia 6
Totale 9.157
Salva come PNG Salva come JPEG
Nome #
Carbohydrate 19.9 Antigen Serum Levels in Liver Disease 140
Commentary on "Insertion of Totally Implantable Central Venous Access Devices by Surgeons" - What Is the Role of Surgeons When Implanting a Totally Implantable Venous Access Device to Prevent Immediate Complications? 140
Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 114
Eterozigosi H36D per Emocromatosi in pazienti affetti da Steatoepatite e Epatite cronica da virus C 113
Immune response in addicts with chronic hepatitis C treated with interferon and ribavirine 108
Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives 105
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance 102
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 101
Anorectal mucosal melanoma 101
Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer 100
Type II Mixed Cryoglobulinemia In Patients With Hepatitis C Virus: Treatment with Pegylated-Interferon and Ribavirin 99
Blood homocysteine levels are increased in hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study 98
Possibile associazione di anemia normocromica con maggiore incremento delle molecole di adesione ICAM-2 e VCAM-1 in pazienti con cirrosi epatica: studio pilota 97
Carotid Intima-Media Thickness and Liver Histology in Hemodialysis Patients with Non-Alcoholic Fatty Liver Disease 96
D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis 96
Hepatocellular carcinoma serum markers 94
Obesity and related diseases: an epidemiologic study in Eastern Sicily 93
A study about mechanism of des-gamma-carboxy prothrombin’s production in hepatocellular carcinoma 93
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 90
High carbohydrate 19-9 antigen serum levels in patients with nonmelanoma skin cancer and primary occult cancer 90
Eritropoietina nel trattamento dell'anemia secondaria a terapia con interferone peghilato e ribavirina 89
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 88
Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis 87
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study 87
Laparoscopic Reversal of Hartmann's Procedure: State of the Art 20 Years after the First Reported Case 86
Rosuvastatin reduces non alcoholic fatty liver diseasa in patients with chronic hepatitis C treated with alpha-interferon and ribavirin 85
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 84
Assessing degree of hepatic fibrosis in patients with chronic liver disease using gadoxetic acid-enhanced liver MRI: Preliminary results 84
Folate levels in hepatocellular carcinoma patients with portal vein thrombosis 82
Trattamento con peg-interferone e ribavirina nell’epatite cronica attiva C ed insorgenza di malattia celiaca: esiste una relazione ? 81
Homocysteine serum levels as prognostic marker of hepatocellular carcinoma with portal vein thrombosis 81
Evaluation of health status in patients with hepatitis c treated with and without interferon 80
Epatite cronica: un caso di sovrapposizione epatite autoimmune-epatite virale 79
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature 79
Giant cavernous liver hemangiomas: is it the time to change the size categories? 79
Circulating adhesion molecules in patients with virus-related chronic diseases of the liver 78
Carnitine Serum Levels in Frail Older Subjects 78
Trattamento dell'epatite cronica B, HBeAg negativa, con terapia di combinazione: Adefovir e Interferone-Pegilato alfa 2a vs Adefovir (Studio PAC: Peg Adefovir Combination) 77
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions 77
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 77
Systemic Therapies in Hepatocellular carcinoma: present and future 76
Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic epatiti C treated with pegylated interferon α and ribavirin 76
Resveratrol in Patients with Minimal Hepatic Encephalopathy 76
ON-TREATMENT HBsAg DECLINE IS ASSOCIATED WITH SUBSEQUENT HBsAg REDUCTION IN HBeAg NEGATIVE CHRONIC HEPATITIS B 74
Riduzione della densità minerale ossea volumetrica (pQCT) in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 74
Acetyl-L-carnitine can slow the progression from prefrailty to frailty in older subjects. A randomized interventional clinical trial 73
Incidence and causes of neonatal hyperbilirubinemia in a center of Catania 72
Rare benign tumors of the liver: still rare? 72
Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study 72
Circulating erytropoietin in microalbuminuric type 2 diabetic patients with normal renal function: a pilot study 71
A therapeutic education and medical support program improves adherence to therapy with peg-interferon plus ribavirin therapy and increases sustained virological response in patients with chronic hepatitis C 71
Hepatocellular Carcinoma: present and future 71
A lethal complication after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. 70
AIDS. Sindrome da Immunodeficienza Acquisita 70
A case of Overlap Syndrome:Autoimmune idiopatic hepatitis/pulmonary idiopatic hypertension 70
Totally Implantable Venous Access Devices: Efforts Are Needed to Standardize Procedures to Avoid Complications 70
Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis 70
Chronic hepatitis C: This and the new era of treatment 69
Association Between Diabetes Mellitus, Hepatic Steatosis And Fibrosis In Chronic Hepatitis C Patients 69
A phase IIIb, 2X2 factorial, double blind study of 48 versus 96 weeks of peg-Interferon alpha 2a 180 micrg, with or without 24 weeks of Entecavir in adult patients with HbeAg negative chronic hepatitis B 69
Endozepine-4 levels are increased in hepatic coma. 69
Genotype-phenotype variable correlation in Wilson disease: clinical history of two sisters with the similar genotype 69
Biochemical long-term outcomes in chronic hepatitis C patients treated with a twelve months course of alpha lymphoblastoid interferon 68
Combined duodenal and pancreatic major trauma in high risk patients: can a partial reconstruction be safe? 68
Current practice of chronic hepatitis B treatment in Southern Italy 68
Potential role of probiotics on colorectal cancer prevention 68
Chronic anaemia and adhesion molecules in patients with liver cirrhosis. A preliminary report 67
Priority of the chronic HBV pathology in a samples of subjects suffering from liver disorder and hospitalized in the last triennium 67
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 67
Eritropoietina nel trattamento dell’anemia secondaria a terapia con interferone peghilato e ribavirina 67
Vaccinazione anti-epatite B: differenze della risposta immune con Hevac B Pasteur in rapporto all'età 67
Hepatocellular carcinoma and the risk of occupational exposure. 67
Silybin supplementation during HCV therapy with pegylated interferon-a plus ribavirin reduces depression and anxiety and increases work ability 67
Reduction of volumetric bone mineral density in postmenopausal women with HCV-correlated chronic liver disease: a peripheral quantitative computed tomogtraphy (pQCT) study 67
An unusual case of HBV reactivation in a patient with cholangitis and choledocho-lithiasis undergone to ERCP. A case report 67
Hepatocellular Carcinoma 66
Carbohydrate 19-9 antigen in chronic viral hepatitis without neoplasia is associated with the severity of liver disease 65
INFEZIONE DA HAV IN PAZIENTI CON EPATITE CRONICA HCV-CORRELATA 65
POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 65
ON-TREATMENT SERUM HBsAG DECLINE DURING TELBIVUDINE THERAPY IN NAÏVE CHRONIC HEPATITIS B: CASE REPORT 64
Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study 64
Respiratory and Cardiovascular Health Effects of e-Cigarette Substitution: Protocol for Two Living Systematic Reviews 64
Experience with vaccination against hepatitis B 63
Does follow-up offer the best quality of life for patients affected by so-called 'giant' haemangiomas of the liver? 63
Telbivudine on-treatment HBsAg loss in naïve HBeAg negative chronic hepatitis B: A case report and brief review of the literature 63
Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis 63
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients. 63
The HCV Sicily Network: a web-based model for the management of HCV chronic liver diseases 62
What are the true advantages of devices for hepatic parenchimal transection in open surgery? 62
Iron depletion and lifestyle modifications improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia 62
Polyunsaturated phosphatidylcholine (EPL) in the management of liver steatosis 61
Behavior of alpha-1-antitrypsin in adults with chronic liver disease 61
La metalloproteinasi-2 è un marker indiretto di citonecrosi e fibrosi epatica nell’epatite cronica HCV-correlata 61
Pegylated-interferon and ribavirin therapy of HCV-related type II mixed cryoglobulinemia 61
A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin 61
Some patients with HCC havent't abnormal des-gamma-carboxy prothrombin and alpha-fetoprotein levels 61
Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria 60
Incidence of Hepatocellular Carcinoma in Patients with HCV-associated Cirrhosis Treated with Direct-Acting Antiviral Agents 60
SAFETY AND EFFICACY OF LOW DOSAGE OF FONDAPARINUX IN CIRRHOTIC PATIENTS WITH PORTAL VEIN THROMBOSIS 60
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment 59
Totale 7.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.127
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.127
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.374 19 114 169 40 377 49 159 18 102 60 187 80
2021/20221.744 223 281 20 27 270 14 256 55 137 6 62 393
2022/20232.628 258 99 40 231 242 445 17 452 678 25 81 60
2023/20241.228 69 163 45 57 50 266 24 91 13 41 231 178
2024/20254.880 79 759 306 226 1.008 553 151 190 345 541 348 374
2025/2026248 248 0 0 0 0 0 0 0 0 0 0 0
Totale 14.162